Capricor Therapeutics Inc... (CAPR)
NASDAQ: CAPR
· Real-Time Price · USD
7.96
0.18 (2.31%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.57%
After-hours: Aug 15, 2025, 07:58 PM EDT
Capricor Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 13.39M | 17.36M | 22.27M | 23.23M | 27.15M | 27.1M | 25.18M | 14.05M | 9.46M | 5.54M | 2.55M | 1.59M | n/a | 204.08K | 244.9K | 302.73K | 319.59K | 165.37K |
Cost of Revenue | 1.14M | 1.14M | 736.87K | 361.17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 12.25M | 15.86M | 21.18M | 22.2M | 26.21M | 26.27M | 24.12M | 13.12M | 8.64M | 4.97M | 2.21M | 1.43M | n/a | 204.08K | 244.9K | 228.03K | 244.9K | 90.68K |
Operating Income | -27.76B | -57.28M | -42.56M | -36.15M | -30M | -26.16M | -24.08M | -30.86M | -30.48M | -30.05M | -29.7M | -28.01M | -25.85M | -23.61M | -20.94M | -18.74M | -18.34M | -16.74M |
Interest Income | 1.87M | 1.87M | 1.14M | 453.15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -25.95B | -55.07M | -40.47M | -34.11M | -27.95M | -24.31M | -22.29M | -29.25M | -29.23M | -28.97M | -29.02M | -27.49M | -25.05M | -22.69M | -20.02M | -18.01M | -17.99M | -16.72M |
Net Income | -25.95B | -55.07M | -40.47M | -34.11M | -27.95M | -24.31M | -22.29M | -29.25M | -29.23M | -28.97M | -29.02M | -27.49M | -25.05M | -22.69M | -20.02M | -18.01M | -17.99M | -16.72M |
Selling & General & Admin | 5.69B | 16.17M | 14.22M | 13.11M | 12.72M | 12.56M | 12.06M | 11.87M | 11.53M | 11.13M | 10.43M | 9.75M | 8.99M | 8.42M | 7.61M | 6.99M | 6.49M | 6.31M |
Research & Development | 22.09B | 57.78M | 49.97M | 45.35M | 43.58M | 39.89M | 36.45M | 32.74M | 28.21M | 24.36M | 21.82M | 19.85M | 16.86M | 15.39M | 13.57M | 12.05M | 12.17M | 10.6M |
Other Expenses | -204.58K | -47.78K | -85.48K | 550.55K | 865.08K | 805.58K | 745.69K | 303.32K | 189.65K | 92.35K | n/a | n/a | n/a | n/a | n/a | -2.75M | -2.75M | -2.75M |
Operating Expenses | 27.78B | 73.91M | 64.1M | 59.02M | 57.16M | 53.26M | 49.26M | 44.91M | 39.93M | 35.59M | 32.25M | 29.6M | 25.85M | 23.81M | 21.18M | 16.3M | 15.91M | 14.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 59.08M | 74.65M | 64.84M | 59.38M | 57.16M | 53.26M | 49.26M | 44.91M | 39.93M | 35.59M | 32.25M | 29.6M | 25.85M | 23.81M | 21.18M | 19.04M | 18.66M | 16.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 45.71M | 45.64M | 35.22M | 33.09M | 31.84M | 31.36M | 26.78M | 25.82M | 25.34M | 25.25M | 25.16M | 24.43M | 24.32M | 24.28M | 24.15M | 23.09M | 22.86M | 22.23M |
Shares Outstanding (Diluted) | 45.71M | 45.64M | 35.22M | 33.09M | 31.84M | 31.36M | 26.78M | 25.82M | 25.34M | 25.25M | 25.16M | 24.43M | 24.32M | 24.28M | 24.15M | 23.09M | 22.86M | 22.23M |
EPS (Basic) | -1.64 | -1.42 | -1.2 | -1.06 | -0.93 | -0.87 | 15.63 | 15.34 | 15.33 | 15.34 | -1.17 | -1.12 | -1.03 | -0.96 | -0.87 | -0.82 | -0.85 | -0.87 |
EPS (Diluted) | -1.64 | -1.42 | -1.2 | -1.06 | -0.93 | -0.87 | 15.63 | 15.34 | 15.33 | 15.34 | -1.17 | -1.12 | -1.03 | -0.96 | -0.87 | -0.82 | -0.85 | -0.87 |
EBITDA | -27.76B | -55.78M | -41.14M | -34.79M | -28.73M | -24.99M | -23.01M | -29.91M | -29.66M | -29.38M | -29.16M | -27.59M | -25.5M | -23.32M | -20.69M | -18.53M | -18.16M | -16.58M |
EBIT | -45.69M | -57.28M | -42.56M | -36.15M | -30M | -26.16M | -24.08M | -30.86M | -30.48M | -30.05M | -29.7M | -28.01M | -25.85M | -23.61M | -20.94M | -18.74M | -18.34M | -16.74M |
Depreciation & Amortization | 1.14M | 1.5M | 1.43M | 1.36M | 1.27M | 1.17M | 1.07M | 952.88K | 813.43K | 670.74K | 533.13K | 420.17K | 347.87K | 288.05K | 245.7K | 209.13K | 180.61K | 161.05K |